T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Intel
INTC
|
+$1.59B |
| 2 |
Dollar General
DG
|
+$1.53B |
| 3 |
Charles Schwab
SCHW
|
+$1.19B |
| 4 |
Uber
UBER
|
+$971M |
| 5 |
Nike
NKE
|
+$868M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.83B |
| 2 |
Amazon
AMZN
|
+$2.33B |
| 3 |
NVIDIA
NVDA
|
+$1.75B |
| 4 |
Humana
HUM
|
+$1.46B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
Sector Composition
| 1 | Technology | 31.18% |
| 2 | Healthcare | 15.82% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Cimpress
CMPR
$1.47B
| $912K | ﹤0.01% |
11,391
-8
| -0.1% | -$641 |
|
1902
GlobalFoundries
GFS
$17.7B
| $911K | ﹤0.01% |
15,032
+1,945
| +15% | +$118K |
|
1903
Vericel Corp
VCEL
$1.62B
| $911K | ﹤0.01% |
25,559
+170
| +0.7% | +$6.06K |
|
1904
Sera Prognostics
SERA
$120M
| $909K | ﹤0.01% |
+151,933
| New | +$909K |
|
1905
Cushman & Wakefield
CWK
$3.83B
| $907K | ﹤0.01% |
83,922
+28,104
| +50% | +$304K |
|
1906
Myriad Genetics
MYGN
$716M
| $905K | ﹤0.01% |
47,231
+440
| +0.9% | +$8.43K |
|
1907
iRobot
IRBT
$112M
| $902K | ﹤0.01% |
23,293
+727
| +3% | +$28.2K |
|
|
CIM
1908
Chimera Investment
CIM
$1.16B
| $902K | ﹤0.01% |
60,216
+1,449
| +2% | +$21.7K |
|
1909
Banc of California
BANC
$2.63B
| $900K | ﹤0.01% |
67,006
+41,345
| +161% | +$555K |
|
1910
Bumble
BMBL
$709M
| $899K | ﹤0.01% |
60,943
+2,599
| +4% | +$38.3K |
|
1911
Utz Brands
UTZ
$1.11B
| $899K | ﹤0.01% |
55,339
+12,759
| +30% | +$207K |
|
1912
German American Bancorp
GABC
$1.52B
| $898K | ﹤0.01% |
27,693
+811
| +3% | +$26.3K |
|
1913
Vanguard Growth ETF
VUG
$190B
| $898K | ﹤0.01% |
2,888
-211
| -7% | -$65.6K |
|
1914
Triumph Financial, Inc.
TFIN
$1.36B
| $896K | ﹤0.01% |
11,168
+6,192
| +124% | +$497K |
|
|
RCM
1915
DELISTED
R1 RCM Inc. Common Stock
RCM
| $895K | ﹤0.01% |
84,672
+14,723
| +21% | +$156K |
|
1916
Chefs' Warehouse
CHEF
$2.71B
| $893K | ﹤0.01% |
30,340
+1,389
| +5% | +$40.9K |
|
1917
STAAR Surgical
STAA
$1.39B
| $890K | ﹤0.01% |
28,497
+1,907
| +7% | +$59.6K |
|
1918
Sally Beauty Holdings
SBH
$1.5B
| $888K | ﹤0.01% |
66,808
+9,574
| +17% | +$127K |
|
1919
Collegium Pharmaceutical
COLL
$1.2B
| $885K | ﹤0.01% |
28,747
+766
| +3% | +$23.6K |
|
1920
Ligand Pharmaceuticals
LGND
$3.23B
| $885K | ﹤0.01% |
12,382
+860
| +7% | +$61.5K |
|
1921
Owens & Minor
OMI
$414M
| $880K | ﹤0.01% |
45,615
+1,862
| +4% | +$35.9K |
|
|
DEA
1922
Easterly Government Properties
DEA
$1.06B
| $879K | ﹤0.01% |
26,160
+1,189
| +5% | +$40K |
|
1923
West Bancorporation
WTBA
$343M
| $877K | ﹤0.01% |
41,347
+6,800
| +20% | +$144K |
|
1924
Eagle Bancorp
EGBN
$615M
| $876K | ﹤0.01% |
29,035
+1,120
| +4% | +$33.8K |
|
|
MODV
1925
DELISTED
ModivCare
MODV
| $875K | ﹤0.01% |
19,875
-3,541
| -15% | -$156K |
|